E. Quoix (Strasbourg, France), Y. Gkiozos (Athens, Greece)
Do patients and carers benefit from attending a dedicated lung cancer support group?
J. Byers, G. Rough, D. Anderson, D. Raeside, J. Sarvesvaran (Glasgow, United Kingdom)
|  |
Clinical trials in advanced stage lung cancer: A survey of patients‘ opinion about their treatment
B. Zaric, B. Perin, A. Ilic, J. Stanic, N. Secen, T. Sarcev, M. Antonic (Sremska Kamenica, Republic Of Serbia)
| |
Survival with in-operable non-small cell lung cancer in U.K district general hospital: Is chemotherapy better than active supportive care?
A. Ali, R. Lewis (Worcester, United Kingdom)
| |
Lung cancer patient evaluation of performance status as a prognostic factor
M. T. Almodovar, M. P. Ferreira, S. Marques, J. Dionisio, J. Gramacho, J. Duro da Costa (Lisbon, Portugal)
| |
Observations on quality of life assessments using functional assessment of cancer-Lung (FACT-L) in patients under lung cancer chemotherapy. Ongoing study
H. Lithoxopoulou, K. Zarogoulidis, S. Bostantzopoulou, E. Eleftheriadou, T. Kontakiotis (Thessaloniki, Greece)
|  |
Exploring patient perceptions of their COPD or lung cancer multidisciplinary team
C. Blunt, J. Curzio, T. Leiba, S. Elkin (London, United Kingdom)
| |
Emphysema, airway obstruction and prognosis in lung cancer
J. A. Gullón, I. Suárez, A. Medina, C. Cabrera, R. Galindo, G. Ramos, H. González, I. J. González (La Laguna, Spain)
| |
Does zingiber officinalis have effect on nausea and vomiting in lung cancer patients with cisplatin based regimen?
S. Baniasadi, F. Fahimi, S. Amini, K. Khodadad, F. Naghibi, G. Radmand (Tehran, Islamic Republic Of Iran)
| |
The reasons and frequency of complementary and alternative medication (CAM) use among lung cancer patients
S. Alpar, B. Kurt, U. Turay, M. Gülhan, B. Ulubas, C. Özdilekcan, H. Bayiz, N. Basay, S. Aslan, M. Önal, S. Arinç, S. S. Hacievliyagil, E. Akpinar, D. Ernam, M. Kiyik (Ankara, Bolu, , Sivas, Istanbul, Malatya, Turkey)
| |
Causes of burnout in health care personnel working in oncology and coping methods they use
V. Isikhan, E. Gulec Balbay, O. Balbay, A. N. Annakkaya, P. Arbak (Ankara, Duzce, Turkey)
| |
Clinical profile of patients with lung cancer submitted to the pulmonary rehabilitation and conventional physiotherapy
M. T. Aguiar P. Morano, E. Delgado de Barros Pereira, M. O. de Moraes, A. Silva da Costa, T. E. Pessoa Morano Macedo, I. Correa Nogueira (Fortaleza, Brasilia, Brazil)
| |
Lung cancer patients hospitalized for febrile neutropenia: A retrospective study
P. Caetano Mota, F. Soares Pires, C. Damas, V. Hespanhol (Porto, Portugal)
| |
Efficacy and safety of erythropoietic agents in anaemic patients with lung cancer (LC)
A. Tiotiu, B. Godbert, Y. Martinet (Nancy, France)
| |
Causes of death according to the histological type in lung cancer patients
S. Ekici, S. Erturan, M. Yaman, G. Aydin (Istanbul, Turkey)
| |
Analysis of risk factors for brain metastasis in locally advanced stage non-small cell carcinoma
S. Arinc, A. Hazar, M. Taylan, S. Karabulut, F. Oruc, A. Mayadagli, A. Kosif, M. Demir, L. Alpay, A. Atasalihi (Istanbul, Turkey)
| |
Comorbidity in lung cancer patients
E. Budišin, N. Budišin, B. Andelic, B. Zaric (Sremska Kamenica, Republic Of Serbia)
| |
Venous thromboembolism and pulmonary cancer: A ten years series
H. Benabdelghaffar, L. Elfekih, H. Hassene, S. Fenniche, I. Akrout, D. Belhabib, M. L. Megdiche (Ariana, Tunisia)
| |
Risk factors for vascular events during lung cancer chemotherapy
K. Murata, M. Takamori, A. Wada, A. Fujita (Japan)
| |
Endoscopic photodynamic therapy with e6 chlorine in advanced stage lung cancer: Preliminary results
A. Akopov, V. Molodtsova, A. Rusanov, I. Chistiakov, N. Kozakov (Saint-Petersburg, Russian Federation)
| |